# Seres Therapeutics, Inc. (MCRB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MCRB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 358.0K | $ -19.91M | $ -16.36M | $ 80.50M | $ 26.50M |
| 2025 | $ 807.9K | $ 5.83M | $ 885.7K | $ 82.97M | $ 44.22M |
| 2024 | $ 0 | $ 142.9K | $ -156.60M | $ 91.64M | $ 13.78M |
| 2023 | $ 136.25M | $ -122.96M | $ -135.51M | $ 198.78M | $ -44.86M |
| 2022 | $ 7.96M | $ -279.45M | $ -266.58M | $ 162.59M | $ 10.78M |
| 2021 | $ 172.27M | $ -77.95M | $ -3.42M | $ 49.21M | $ 131.51M |
| 2020 | $ 42.31M | $ -113.54M | $ -120.01M | $ 40.77M | $ 174.75M |
| 2019 | $ 44.54M | $ -90.71M | $ -100.61M | $ 44.78M | $ -48.32M |
| 2018 | $ 37.33M | $ -130.67M | $ -85.57M | $ 7.25M | $ -48.05M |
| 2017 | $ 43.24M | $ -120.41M | $ -108.04M | $ 8.99M | $ 60.70M |
| 2016 | $ 29.94M | $ -126.00M | $ 30.86M | $ 10.73M | $ 132.63M |
| 2015 | $ 0 | $ -76.91M | $ -63.47M | $ 0 | $ 205.39M |
| 2014 | $ 0 | $ -23.61M | $ -16.05M | $ 2.50M | $ -26.72M |
| 2013 | $ 0 | $ -3.09M | $ -2.37M | $ 838.0K | $ 631.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 3.04 |
| Liabilities / Eq | 3.44 |
| Current Ratio | 1.65 |

## Other views

- [Metrics](https://sponda.capital/en/MCRB.md)
- [Charts](https://sponda.capital/en/MCRB/charts.md)
- [Compare](https://sponda.capital/en/MCRB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.